Recurring shingles, especially affecting the eye and forehead, is definitely worth discussing with your MG specialist before making any vaccine decisions. The shingles vaccine (Shingrix) is a non-live vaccine, which is generally considered safer for people with MG — especially those on immunosuppressive treatments.
Here's Show Full Answer
Recurring shingles, especially affecting the eye and forehead, is definitely worth discussing with your MG specialist before making any vaccine decisions. The shingles vaccine (Shingrix) is a non-live vaccine, which is generally considered safer for people with MG — especially those on immunosuppressive treatments.
Here's what to keep in mind: - Live vaccines are generally avoided if you're on immunosuppressive therapy for MG
- Shingrix is not a live vaccine, making it a more suitable option for many people with MG
- Your immune response to the vaccine may be reduced if you're on immunosuppressants, but it can still offer meaningful protection
- Timing matters — your doctor can advise the best time to vaccinate based on your current MG treatment schedule
The benefits of vaccination typically outweigh the risks, particularly when shingles keeps coming back. A weaker immune response to the vaccine is still better than no protection at all.
Definitely bring this up with your MG specialist or neurologist — they can factor in your specific treatment plan and immune function to give you the most personalized guidance.
5 days ago
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
